Jacopo Mariotti, MD, Humanitas Research Hospital, Milan, Italy, presents a retrospective study on the efficacy of EBMT criteria in diagnosing thrombotic microangiopathy (TMA) post-allogeneic stem cell transplantation (alloSCT). The study confirms the criteria's robust diagnostic capability, with patients meeting four or more criteria exhibiting poorer prognoses, especially those with C5b-9 complement activation. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть